- Home
- » Tags
- » Polymyxin B
Top View
- Self-Assembling Dipeptide Antibacterial Nanostructures with Membrane Disrupting Activity
- European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Sales Data and Animal Population Data Reporting Protocol (Version 4)
- Swedres-Svarm 2016
- Polymyxin B B
- Recent Advances in Design of Antimicrobial Peptides and Polypeptides Toward Clinical Translation
- A Review of the Clinical Pharmacokinetics of Polymyxin B
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Colistin and Polymyxin B: a Re-Emergence
- Sales of Veterinary Antimicrobial Agents in 31 European Countries in 2018
- Burden and Current Global Management on GNB Infections: Lessons from the Global-PPS of Antimicrobial Consumption and Resistance in 335 Hospitals Worldwide
- Estonian Statistics on Medicines 2014
- Antimicrobial Lipopeptide Tridecaptin A1 Selectively Binds to Gram-Negative Lipid II
- WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC Data, 2014-2018
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- Polymyxin B for Injection, USP
- Polymyxin B for Injection, USP500,000 Units/Vial
- Cefepime Combined with Amoxicillin/Clavulanic Acid: a New Choice For
- Antimicrobial Prescribing Guidelines for Sheep
- Vancomycin Vancomycin Hydrochloride for Injection, USP Hydrochloride for Injection, USP ADD-Vantage™ Vials Rx Only ADD-Vantage™ Vials Rx Only
- Polymyxin Delivery Systems: Recent Advances and Challenges
- Bacitracin, Neomycin, and Polymyxin B (Topical)
- Rational Use of Intravenous Polymyxin B and Colistin: a Review
- In Vitro Synergistic Activity of Carbapenems in Combination with Other Antimicrobial Agents Against Multidrug-Resistant Acinetobacter Baumannii
- Safety Data Sheet
- Microbiology Guide to Interpreting Minimum Inhibitory Concentration (MIC)
- 21 CFR Ch. I (4–1–12 Edition) § 524.1484C
- The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs
- 2019 Antibacterial Agents in Clinical Development
- Polymyxins and Bacterial Membranes: a Review of Antibacterial Activity and Mechanisms of Resistance
- Polymyxin B for Injection Usp
- Penicillin G Procaine, Neomycin and Polymyxin B Sulfates, and Hydrocortisone Acetate Topical Suspension
- FDA Briefing Document Bacitracin For
- Gram Stain Susceptibilities Organism Identification
- BIO4 Antibiotics Expert Committee
- Amc Data 2011–2017
- Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent in Vitro Antiviral Activity Against SARS-Cov-2
- Triple Antibiotic Ointment (Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate)
- Supplementary Material UK-VARSS 2019
- Multi-Drug Resistant Gram Negative Infections and Use of Intravenous
- Bacitracin, Neomycin, Polymyxin B, and Hydrocortisone (Topical)
- In Vitro Activity of Polymyxin B and Meropenem Alone and in Combination Against Carbapenem-Resistant Enterobacteriaceae
- Calorimetric Analysis of the Effects of Penicillin G, Ampicillin and Polymyxin Bon the Growth
- Polymyxin PIL 11.Indd
- Speciation and Antibiotic Susceptibilities of Coagulase Negative Staphylococci Isolated from Ocular Infections
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment
- Rutinemessig Publisering Av Forbruksdata for Antibakterielle Midler Rapportert Til Vetreg VETERINÆRINSTITUTTET
- The Clinical Potential of Antimicrobial Peptides
- 22 June 2021
- Colistin (Colistimethate)
- Development of Novel Antimicrobial Peptides with Improved Hemocompatibility
- Susceptibility to Polymyxin B of Penicillin G-Induced Proteus
- Antimicrobial Resistance in the 21St Century, Emerging Infectious Diseases of the 21St Century, 756 Index
- Effect of Polymyxin B on Antibiotic-Resistant Proteus Mirabilis
- Effect of Polymyxin B Sulfate on Endo Toxin Activity in a Gram-Negative Septicemia Model
- Antimicrobial Medicines Consumption in Eastern Europe and Central Asia – an Updated Cross-National Study and Assessment of Quantitative Metrics for Policy Action
- Triple Antibiotic, Ophthalmic
- Categorisation of Antibiotics for Use in Animals EMA for Prudent and Responsible Use
- Tutorial Article the Current Status of Antibiotic Use in Equine Reproduction M